<p>For years, it was harder for Black patients to secure a coveted spot on the national kidney transplant waitlist because a clinical algorithm was making Black patients appear healthier than they were. After a Penn Medicine researcher exposed the problem in 2019—and showed how it exacerbated racial disparities in kidney disease—a national taskforce recommended removing race from the algorithm’s scoring, a move that has quickly been adopted throughout the country in an effort to reduce racial inequity.</p>
Karla Alexandra Ratliff-Britt - centraljersey.com centraljersey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from centraljersey.com Daily Mail and Mail on Sunday newspapers.
<p><strong>PHILADELPHIA – </strong>The development of any type of second cancer following CAR T cell therapy is a rare occurrence, as found in an analysis of more than 400 patients treated at Penn Medicine, researchers from the Perelman School of Medicine at the University of Pennsylvania reported today in <a href="https://www.nature.com/articles/s41591-024-02826-w"><em>Nature Medicine</em></a>. The team also described a single case of an incidental T cell lymphoma that did not express the CAR gene and was found in the lymph node of a patient who developed a secondary lung tumor following CAR T cell therapy.</p>
Secondary cancers following CAR T cell therap eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
<p>Increasing patients’ out of pocket costs for HIV pre-exposure prophylaxis (PrEP), medications, which have been shown to dramatically reduce the risk of HIV infection, could lead to a significant reduction in PrEP use and a rise in HIV infection rates, according to a new study co-led by researchers at the Perelman School of Medicine at the University of Pennsylvania and Johns Hopkins Bloomberg School of Public Health.</p>